Drugs / Janumet
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Refused (EMA) | EU (EMA) | Janumet | — | 2009-02-18 | europa.eu ↗ |
| Approved | EU (EMA) | Janumet | — | 2008-07-16 | europa.eu ↗ |
| Approved | US (FDA) | JANUMET | — | 2007-03-30 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00684528 | Jun 2008 → Dec 2011 | type 2 diabetes mellitus | Meir Medical Center | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Janumet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00684528 ↗ |
| Known as | Janufer | “Metformin + Janufer (Janumet)” NCT00684528 ↗ |